Latest News

June Halper, MSN
In Memoriam: A Loving Tribute to June Halper

July 24th 2024

NeurologyLive joins the CMSC in mourning the loss of founder and CEO,June Halper, MSN, APC-C, MSCN, FAAN.

Biogen and Sage Terminate Development of SAGE-324 Following Disappointing Phase 2 Data
Biogen and Sage Terminate Development of SAGE-324 Following Disappointing Phase 2 Data

July 24th 2024

Case Study Highlights Therapeutic Potential of Tocilizumab in MOGAD With Cancer
Case Study Highlights Therapeutic Potential of Tocilizumab in MOGAD With Cancer

July 24th 2024

Peter Kang, MD, FAAN, FAAP  (Credit:  University of Minnesota)
FDA Clears IND Application for Myogenica’s MyoPAXon in Muscular Dystrophy

July 24th 2024

Ionis to Advance ION582 in Phase 3 Studies of Angelman Syndrome Following Positive Open-Label Data
Ionis to Advance ION582 in Phase 3 Studies of Angelman Syndrome Following Positive Open-Label Data

July 24th 2024

Coverage of the Third Annual Advanced Therapeutics in Movement & Related Disorders Congress

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor of the ATMRD Congress.

ATMRD 2024

Conference Coverage

View All
NeuroVoices: David Shprecher, DO, MSci, FAAN, on Current and Future Directions in Biomarker Testing for Atypical Parkinsonism
NeuroVoices: David Shprecher, DO, MSci, FAAN, on Current and Future Directions in Biomarker Testing for Atypical Parkinsonism

July 24th 2024

Patricia K. Coyle, MD
Potential of BTK Inhibitors for Primary Progressive Multiple Sclerosis: Patricia K. Coyle, MD

July 23rd 2024

Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
Optimizing Localization in Multiple Sclerosis Diagnosis: Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN

July 23rd 2024

A Comprehensive Program to Enhance Inpatient Care for Patients With Parkinson Disease
A Comprehensive Program to Enhance Inpatient Care for Patients With Parkinson Disease

July 22nd 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.